Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Sanofi
SNY
$104B
| $26M | 0.02% |
521,551
+50,720
| +11% | +$2.45M |
|
677
Agios Pharmaceuticals
AGIO
$2.16B
| $25.9M | 0.02% |
388,536
-8,418
| -2% | -$506K |
|
678
RLI Corp
RLI
$5.68B
| $25.9M | 0.02% |
903,638
+4,996
| +0.6% | +$137K |
|
679
Pool Corp
POOL
$6.7B
| $25.8M | 0.02% |
238,706
+37,032
| +18% | +$4.01M |
|
|
BHVN
680
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $25.8M | 0.02% |
688,909
+43,166
| +7% | +$1.31M |
|
681
Zillow
Z
$7.04B
| $25.7M | 0.02% |
640,207
+43,048
| +7% | +$1.82M |
|
682
AXIS Capital
AXS
$8.59B
| $25.7M | 0.02% |
448,588
-247,000
| -36% | -$15.2M |
|
683
Rockwell Automation
ROK
$51.4B
| $25.7M | 0.02% |
144,214
-55,191
| -28% | -$9.18M |
|
684
iShares S&P India Nifty 50 Index Fund
INDY
$545M
| $25.7M | 0.02% |
751,900
+9,700
| +1% | +$341K |
|
685
Graco
GGG
$12.9B
| $25.4M | 0.02% |
615,006
-295,521
| -32% | -$11.3M |
|
686
Avery Dennison
AVY
$12.3B
| $25.4M | 0.02% |
257,775
+25,922
| +11% | +$2.44M |
|
687
Flowserve
FLS
$9.25B
| $25M | 0.02% |
587,871
+4,934
| +0.8% | +$208K |
|
688
Yum! Brands
YUM
$41B
| $24.7M | 0.02% |
335,848
-20,914
| -6% | -$1.57M |
|
689
Strategy Inc
MSTR
$33.5B
| $24.6M | 0.02% |
1,929,160
+847,210
| +78% | +$12.3M |
|
690
AstraZeneca
AZN
$263B
| $24.6M | 0.02% |
363,300
+357,094
| +5,754% | +$22.6M |
|
691
AngioDynamics
ANGO
$562M
| $24.6M | 0.02% |
1,439,873
+476,327
| +49% | +$8M |
|
692
Ecolab
ECL
$75.6B
| $24.6M | 0.02% |
191,060
+8,748
| +5% | +$1.15M |
|
|
DRE
693
DELISTED
Duke Realty Corp.
DRE
| $24.5M | 0.02% |
850,962
+395,902
| +87% | +$11.4M |
|
|
TPGE.U
694
DELISTED
TPG Pace Energy Holdings Corp.
TPGE.U
| $24.5M | 0.02% |
2,413,170
-845,153
| -26% | -$8.68M |
|
695
Paycom
PAYC
$6.78B
| $24.3M | 0.02% |
324,630
-97,065
| -23% | -$6.95M |
|
696
IMAX
IMAX
$2.38B
| $24.2M | 0.02% |
1,068,456
+506,705
| +90% | +$10.4M |
|
697
ePlus
PLUS
$2.33B
| $24M | 0.02% |
519,630
-155,194
| -23% | -$6.33M |
|
|
DFRG
698
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $23.9M | 0.02% |
1,645,901
+802,824
| +95% | +$11.6M |
|
699
Dentsply Sirona
XRAY
$2.59B
| $23.9M | 0.02% |
400,336
-25,853
| -6% | -$1.54M |
|
700
SiriusXM
SIRI
$10B
| $23.8M | 0.02% |
430,803
-482,430
| -53% | -$26.7M |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.